Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism
Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism Isabelle Mahé, M.D.,…
Ler MaisManagement strategies and clinical outcomes of venous thromboembolism in patients with antiphospholipid syndrome in the direct oral anticoagulant era: Insight from the COMMAND VTE Registry-2
Management strategies and clinical outcomes of venous thromboembolism in patients…
Ler MaisThe efficacy and safety of low-molecular-weight heparins for venous thromboembolism prophylaxis in abdominal or pelvic cancer surgery: A systematic review and network meta-analysis of randomized controlled trials
The efficacy and safety of low-molecular-weight heparins for venous thromboembolism…
Ler MaisAssociation between anticoagulant-related bleeding and mortality in patients with hematological malignancies and cancer-associated venous thromboembolism
Association between anticoagulant-related bleeding and mortality in patients with hematological…
Ler MaisAssociation between anticoagulant-related bleeding and mortality in patients with hematological malignancies and cancer-associated venous thromboembolism
Association between anticoagulant-related bleeding and mortality in patients with hematological…
Ler MaisMitochondrial DNA copy number and its association with venous thromboembolism in patients with cancer
Mitochondrial DNA copy number and its association with venous thromboembolism…
Ler MaisNatural history of untreated acute pulmonary embolism in patients with cancer: A retrospective cohort of missed pulmonary emboli
Natural history of untreated acute pulmonary embolism in patients with…
Ler MaisUnveiling the trends: Growing cancer and venous thromboembolism mortality in older adults in the United States, 1999–2020
Unveiling the trends: Growing cancer and venous thromboembolism mortality in…
Ler MaisRisk assessment and prevention of cancer-associated venous thromboembolism in ambulatory patients with solid malignancies
Risk assessment and prevention of cancer-associated venous thromboembolism in ambulatory…
Ler MaisChemotherapy alters thrombomodulin and factor VIIIc expression resulting in acquired activated protein C resistance and enhanced thrombin generation in cancer associated thrombosis
Chemotherapy alters thrombomodulin and factor VIIIc expression resulting in acquired…
Ler Mais